HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lotfi Chouchane Selected Research

Drug-Related Side Effects and Adverse Reactions

1/2018Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lotfi Chouchane Research Topics

Disease

43Neoplasms (Cancer)
01/2022 - 09/2002
21Breast Neoplasms (Breast Cancer)
06/2021 - 09/2002
16Nasopharyngeal Carcinoma
01/2016 - 09/2002
8Prostatic Neoplasms (Prostate Cancer)
01/2019 - 07/2006
7Neoplasm Metastasis (Metastasis)
06/2021 - 09/2007
5Lymphatic Metastasis
04/2013 - 01/2006
4Carcinogenesis
01/2022 - 02/2008
4Ductal Carcinoma
12/2012 - 11/2005
3Melanoma (Melanoma, Malignant)
11/2020 - 04/2012
3Infections
01/2020 - 04/2009
3Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 09/2002
2Testicular Neoplasms (Testicular Cancer)
05/2014 - 04/2012
2Disease Progression
04/2013 - 05/2011
2Liver Cirrhosis (Hepatic Cirrhosis)
06/2011 - 04/2009
2Hepatitis C
06/2011 - 04/2009
2Chronic Hepatitis C
06/2011 - 04/2009
2Carcinoma (Carcinomatosis)
04/2010 - 07/2006
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Colonic Neoplasms (Colon Cancer)
01/2022
1COVID-19
01/2021
1Inflammation (Inflammations)
12/2020
1Chronic Disease (Chronic Diseases)
12/2020
1Familial Mediterranean Fever (Periodic Disease)
10/2020
1Xeroderma Pigmentosum (Kaposi's Disease)
01/2020
1Squamous Intraepithelial Lesions
01/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018
1Drug-Related Side Effects and Adverse Reactions
01/2018
1Triple Negative Breast Neoplasms
01/2017
1Stomach Neoplasms (Stomach Cancer)
05/2015
1Dyslipidemias (Dyslipidemia)
01/2014
1Medullary Carcinoma
12/2012
1Lobular Carcinoma
12/2012

Drug/Important Bio-Agent (IBA)

10Genetic Markers (Genetic Marker)IBA
10/2012 - 05/2005
9Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2002
8EnzymesIBA
01/2016 - 05/2005
4MicroRNAs (MicroRNA)IBA
01/2022 - 05/2015
4DNA (Deoxyribonucleic Acid)IBA
11/2020 - 09/2008
4Molecular Chaperones (Chaperone, Molecular)IBA
12/2012 - 02/2008
4HLA Antigens (Human Leukocyte Antigens)IBA
08/2011 - 04/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2010 - 07/2006
3AntibodiesIBA
01/2021 - 07/2008
3Immunoglobulin G (IgG)IBA
01/2020 - 09/2002
3Cadherins (E-Cadherin)IBA
01/2017 - 09/2010
3AntigensIBA
05/2014 - 07/2008
3Biomarkers (Surrogate Marker)IBA
10/2012 - 06/2009
3CytokinesIBA
06/2011 - 12/2005
3Interleukin-8 (Interleukin 8)IBA
06/2010 - 01/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2007 - 04/2003
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2020 - 01/2017
2Hormones (Hormone)IBA
01/2019 - 12/2012
2Formaldehyde (Formol)FDA Link
12/2017 - 06/2009
2ParaffinIBA
12/2017 - 06/2009
2Biological ProductsIBA
12/2017 - 01/2017
2Interleukin-6 (Interleukin 6)IBA
05/2015 - 12/2005
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2015 - 01/2009
2InterferonsIBA
08/2011 - 06/2011
2Interleukin-10 (Interleukin 10)IBA
06/2011 - 04/2009
2Interleukin-18 (Interleukin 18)IBA
06/2011 - 08/2008
2ChemokinesIBA
06/2010 - 09/2007
2HaptoglobinsIBA
06/2009 - 07/2008
2Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
04/2009 - 09/2007
2TubulinIBA
07/2008 - 09/2002
2Heat-Shock Proteins (Heat-Shock Protein)IBA
02/2008 - 04/2003
2Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
02/2008 - 01/2008
2Phosphopyruvate Hydratase (Enolase)IBA
02/2008 - 01/2008
2AutoantibodiesIBA
02/2006 - 09/2002
1Immune Checkpoint InhibitorsIBA
01/2022
1human MIRN149 microRNAIBA
01/2022
1N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
01/2022
1Protein Kinase InhibitorsIBA
01/2022
1Environmental Pollutants (Pollutants, Environmental)IBA
12/2020
1RNA (Ribonucleic Acid)IBA
11/2020
1Amino AcidsFDA Link
11/2020
1Interleukin-33IBA
10/2020
1Peptides (Polypeptides)IBA
01/2020
1Transforming Growth Factor beta (TGF-beta)IBA
01/2020
1Oncogene Proteins (Oncogene Protein)IBA
01/2020
1Phenobarbital (Luminal)FDA Link
01/2019
1Enhancer of Zeste Homolog 2 ProteinIBA
01/2019
1Pharmaceutical PreparationsIBA
01/2018
1Small Untranslated RNAIBA
12/2017
1NeuropeptidesIBA
01/2017
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
01/2017
1Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
01/2017
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2016
1Dinoprostone (PGE2)FDA Link
05/2015
1InterleukinsIBA
05/2015
1ApolipoproteinsIBA
01/2014
1Triglycerides (Triacylglycerol)IBA
01/2014
1Messenger RNA (mRNA)IBA
05/2013
1CalreticulinIBA
04/2013
1Crystallins (Crystallin)IBA
12/2012
1P-2 (P 2)IBA
10/2012

Therapy/Procedure

9Therapeutics
06/2021 - 09/2002
5Immunotherapy
01/2022 - 04/2012
5Lasers (Laser)
04/2013 - 01/2008
2Precision Medicine
12/2020 - 01/2017
2Aftercare (After-Treatment)
05/2011 - 04/2008
1Castration
01/2019
1Drug Prescriptions
01/2018